Analysts at HC Wainwright upped their price objective on shares of Insmed Incorporated (NASDAQ:INSM) from $25.00 to $30.00 in a research report issued to clients and investors on Wednesday, Stock Ratings Network.com reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 63.93% from the stock’s previous close. Insmed Incorporated (NASDAQ:INSM) shares after opening at $16.00 moved to $17.38 on last trade day and at the end of the day closed at $15.09. Company price to sales ratio in past twelve months was calculated as 54.20 and price to cash ratio as 5.47. Insmed Incorporated (NASDAQ:INSM) showed a negative weekly performance of -15.94%.
Cowen and Company started coverage on shares of Idera Pharmaceuticals Inc (NASDAQ:IDRA) in a research report released on Monday morning, TheFlyOnTheWall.com reports. The firm issued an outperform rating on the stock. Idera Pharmaceuticals Inc (NASDAQ:IDRA) shares fell -7.30% in last trading session and ended the day on $4.19. IDRA return on equity ratio is recorded as -444.00% and its return on assets is -114.30%.Idera Pharmaceuticals Inc (NASDAQ:IDRA) yearly performance is 705.77%.
The MannKind Corporation (NASDAQ:MNKD) on Feb. 18 reported financial results for the fourth quarter and full year ended December 31, 2013. The net loss applicable to common stockholders for fiscal year 2013 was $(191.5) million, or $(0.64) per share based on 299.6 million weighted average shares outstanding, compared with a net loss applicable to common stockholders of $(169.4) million, or $(0.94) per share based on 180.9 million weighted average shares outstanding for fiscal year 2012. MannKind Corporation (NASDAQ:MNKD) shares moved down -7.24% in last trading session and was closed at $5.38, while trading in range of $5.29-$5.85.MannKind Corporation (NASDAQ:MNKD) year to date performance is 3.46%.
The business of providing electricity through use of fuel-cells goes beyond the offering ultra-clean and probably cheaper energy. You only need to know what FuelCell Energy Inc (NASDAQ:FCEL)is up to of late to appreciate the ability of fuel-cell companies to kill two birds with one stone. FuelCell Energy Inc (NASDAQ:FCEL) weekly performance is -9.09%. On last trading day company shares ended up $2.40. FuelCell Energy Inc (NASDAQ:FCEL) distance from 50-day simple moving average is 18.28%. Analysts mean target price for the company is $3.08.
Leave a Reply